AstraZeneca logo

AZN - AstraZeneca News Story

7615p 94.0  1.2%

Last Trade - 4:50pm

Sector
Healthcare
Size
Large Cap
Market Cap £98.69bn
Enterprise Value £109.06bn
Revenue £18.76bn
Position in Universe 10th / 1836

BRIEF-AstraZeneca's Imfinzi, Tremelimumab Granted ODD By U.S. FDA

Mon 20th January, 2020 7:22am
Jan 20 (Reuters) - AstraZeneca PLC  AZN.L :
    * IMFINZI, TREMELIMUMAB GRANTED ODD IN LIVER CANCER
    * FDA GRANTS ODD TO MEDICINES INTENDED FOR TREATMENT,
DIAGNOSIS OR
PREVENTION OF RARE DISEASES OR DISORDERS

Source text for Eikon:  ID:nRST2850Aa 
Further company coverage:  AZN.L 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.